Predicting impending beta cell loss and dysglycemia in asymptomatic type 1 diabetes - Validation of minimally invasive markers against the hyperglycemic clamp test. Vrije Universiteit Brussel
We aim to monitor functional beta cell mass and insulin action using
the gold standard hyperglycemic clamp test (HCT) in asymptomatic
type 1 diabetes (T1D) in relation to known determinants of disease
progression. This may help to unravel the heterogeneous nature of
pre-T1D. The majority of beta cell loss is hypothesized to occur within
2 years prior to diagnosis. Simultaneously, promising minimally
...
the gold standard hyperglycemic clamp test (HCT) in asymptomatic
type 1 diabetes (T1D) in relation to known determinants of disease
progression. This may help to unravel the heterogeneous nature of
pre-T1D. The majority of beta cell loss is hypothesized to occur within
2 years prior to diagnosis. Simultaneously, promising minimally
...